VOMERO, SALVATORE
 Distribuzione geografica
Continente #
NA - Nord America 6.990
EU - Europa 5.421
AS - Asia 3.027
SA - Sud America 530
AF - Africa 106
Continente sconosciuto - Info sul continente non disponibili 34
OC - Oceania 8
Totale 16.116
Nazione #
US - Stati Uniti d'America 6.900
GB - Regno Unito 1.318
CN - Cina 1.218
SG - Singapore 859
RU - Federazione Russa 839
IE - Irlanda 670
IT - Italia 544
UA - Ucraina 491
DE - Germania 483
SE - Svezia 468
BR - Brasile 438
FR - Francia 333
HK - Hong Kong 249
VN - Vietnam 237
KR - Corea 178
FI - Finlandia 139
IN - India 84
CA - Canada 40
ES - Italia 40
TR - Turchia 39
AR - Argentina 36
ZA - Sudafrica 28
MX - Messico 26
CI - Costa d'Avorio 25
IQ - Iraq 25
BD - Bangladesh 24
ID - Indonesia 19
EC - Ecuador 17
NG - Nigeria 17
JP - Giappone 14
NL - Olanda 14
BE - Belgio 13
CZ - Repubblica Ceca 12
PL - Polonia 11
AE - Emirati Arabi Uniti 10
CO - Colombia 10
AZ - Azerbaigian 9
CL - Cile 8
CR - Costa Rica 8
KE - Kenya 8
MA - Marocco 8
RO - Romania 8
UZ - Uzbekistan 8
PK - Pakistan 7
PY - Paraguay 7
AT - Austria 6
EE - Estonia 6
EU - Europa 6
JO - Giordania 6
NP - Nepal 6
PH - Filippine 6
DZ - Algeria 5
LT - Lituania 5
SA - Arabia Saudita 5
UY - Uruguay 5
VE - Venezuela 5
AU - Australia 4
EG - Egitto 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
TN - Tunisia 4
BB - Barbados 3
GT - Guatemala 3
HN - Honduras 3
PE - Perù 3
PT - Portogallo 3
TH - Thailandia 3
AL - Albania 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
KG - Kirghizistan 2
LK - Sri Lanka 2
NI - Nicaragua 2
SN - Senegal 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BZ - Belize 1
CG - Congo 1
CV - Capo Verde 1
DK - Danimarca 1
GR - Grecia 1
IR - Iran 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LI - Liechtenstein 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
NO - Norvegia 1
Totale 16.081
Città #
Southend 1.171
Fairfield 816
Dallas 790
Dublin 668
Ashburn 526
Singapore 516
Jacksonville 403
Santa Clara 384
Woodbridge 357
Chandler 350
Wilmington 318
Seattle 288
Cambridge 269
Beijing 255
Houston 248
Hefei 238
Hong Kong 238
Moscow 232
Milan 225
Ann Arbor 188
Seoul 176
San Jose 159
Princeton 156
Nanjing 136
Council Bluffs 125
Los Angeles 95
Siena 87
Ho Chi Minh City 80
Lauterbourg 71
Hanoi 68
Fremont 67
The Dalles 64
Boardman 63
Rome 56
Helsinki 49
Nanchang 49
New York 47
Shenyang 46
Buffalo 43
Munich 42
Bengaluru 40
San Diego 40
Shanghai 38
São Paulo 37
Dearborn 36
Lancaster 32
Düsseldorf 28
Hebei 28
Málaga 28
Abidjan 25
Tianjin 25
Izmir 22
Menlo Park 22
Norwalk 22
Orem 22
San Mateo 22
Frankfurt am Main 20
Jiaxing 20
Jinan 20
Johannesburg 20
San Francisco 19
Changsha 18
Kunming 18
London 18
Venezia 18
Mestre 17
Philadelphia 17
Stockholm 17
Columbus 16
Redwood City 16
Washington 15
Figino 14
Zhengzhou 14
Rio de Janeiro 13
Belo Horizonte 11
Brussels 11
Toronto 11
Turin 11
Abuja 10
Atlanta 10
Haiphong 10
Turku 10
Baghdad 9
Boston 9
Brooklyn 9
Chicago 9
Curitiba 8
Mexico City 8
Montreal 8
Mumbai 8
Ningbo 8
Ottawa 8
Tokyo 8
Baku 7
Brasília 7
Brno 7
Campinas 7
Guangzhou 7
Quito 7
Redondo Beach 7
Totale 11.161
Nome #
Design, Synthesis, and Biological Evaluation of Imidazo[1,5-a]quinoline as Highly Potent Ligands of Central Benzodiazepine Receptors 397
Anionic Polymerization of a Benzofulvene Monomer Leading to a Thermoreversible π-Stacked Polymer. Studies in Macromolecular and Aggregate Structure 355
A Click Chemistry-Based “Grafting Through” Approach to the Synthesis of a Biorelevant Polymer Brush 346
A Nanocomposite Material Formed by Benzofulvene Polymer Nanoparticles Loaded with a Potent 5-HT3 Receptor Antagonist (CR3124) 327
A Non-Peptide NK1 Receptor Agonist Showing Subpicomolar Affinity 300
Combining Spontaneous Polymerization and Click Reactions for the Synthesis of Polymer Brushes: A “Grafting Onto” Approach 273
Bivalent Ligands for the Serotonin 5-HT3 Receptor 271
Characterization of Quinoline Derivatives. II. 7-(4-methyl-1-piperazinyl)-6H-[1]benzopyrano[3,4-c]quinoline 266
Characterization of persistent intramolecular C-H⋅⋅⋅X(N,O) bonds in solid state and solution 254
Synthesis and Spontaneous Polymerization of Oligo(ethylene glycol)-Conjugated Benzofulvene Macromonomers. A Polymer Brush Forming a Physical Hydrogel 252
5-HT and Benzodiazepine Receptor Ligands. III. Synthesis and Receptor Affinities of 1,2,4,-Triazolo[4',3':1,6]pyridazino[4,5-b]quinoline and 2,3-Dihydro-9-phenyl-1H-pyrrolo[3,4-b]quinoline-1-one Derivatives 249
Novel Analgesic/Anti-inflammatory Agents: 1,5-Diarylpyrrole Nitrooxyalkyl Ethers and Related Compounds as Cyclooxygenase-2 Inhibiting Nitric Oxide Donors 248
Design, Synthesis, and Biological Evaluation of AT1 Angiotensin II Receptor Antagonists Based on the Pyrazolo[3,4-b]pyridine and related Heteroaromatic Bicyclic Systems 247
6-(1-Piperazinyl)-7H-indeno[2,1-c]quinoline Derivatives with High Affinity and Selectivity for 5-HT3 Serotonin Sites 244
Amidine, Thiourea and Guanidine Derivatives of 2-Aminobenzothiazoles and Aminobenzothiazines, Novel Pharmacological Agents for the Treatment of Neurodegenerative Pathologies 239
Design, Synthesis, and Preliminary Biological Evaluation of Pyrrolo[3,4-c]quinolin-1-one and Oxoisoindoline Derivatives as Aggrecanase Inhibitors 238
The Interactions of the 5-HT3 Receptor with Quipazine-Like Arylpiperazine Ligands. The Journey Track at the End of the First Decade of the Third Millennium 236
Design, Synthesis, and Structure-Affinity Relationship Studies in NK1 Receptor Ligands Based on Azole-Fused Quinolinecarboxamide Moieties 230
Characterization of Quinoline Derivatives. I. 6,7-Dihydro-8-(4-methyl-1-piperazinyl)[1]benzoxepino[4,5-c]quinoline 0.13-Hydrate 228
Physicochemical and biopharmaceutical characterization of endo-2-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-2,3-dihydro-1H-benz[e]isoindol-1-one (CR3124) a novel potent 5-HT3 receptor antagonist 228
Structural Manipulation of Benzofulvene Derivatives Showing Spontaneous Thermoreversible Polymerization. Role of the Substituents in the Modulation of Polymer Properties 225
Phenylindenone isomers as divergent modulators of p38α MAP kinase 221
11C-Labelling of the 5-HT3 Antagonist VC125 for PET Distribution Studies 219
Synthesis and characterization of charge-transporting π-stacked polybenzofulvene derivatives 212
Synthesis and Structure-Activity Relationship Studies in Translocator Protein Ligands Based on a Pyrazolo[3,4-b]quinoline Scaffold 207
Synthesis and biological evaluation of amidine, guanidine, and thiourea derivatives of 2-amino(6-trifluoromethoxy)benzothiazole as neuroprotective agents potentially useful in brain diseases 205
Synthesis of 2-Substituted-2,3-dihydro-9-phenyl-1H-pyrrolo[3,4-b]quinolin-3-ones as Potential Peripheral Benzodiazepine-receptor Ligands 204
Mapping the Peripheral Benzodiazepine Receptor Binding Site by Conformationally Restrained Derivatives of 1-(2-Chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide (PK11195) 201
Synthesis of 6,7-Dihydro-8-(4-methyl-1-piperazinyl)-[1]benzoxepino[4,5-c]quinoline as Potential 5-HT3 Receptor Ligand 201
Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety 200
Reversible polymerization techniques leading to π-stacked polymers 200
Synthesis, Biological Evaluation, and Quantitative Receptor Docking Simulations of 2-Acylaminoethyl-1,4-benzodiazepines as novel Tifluadom-Like Ligands with High Affinity and Selectivity for k-Opioid Receptors 198
Synthesis, Labeling, and Biological Evaluation of Halogenated 2-Quinolinecarboxamides as Potential Radioligands for the Visualization of Peripheral Benzodiazepine Receptors 196
Novel and Highly Potent 5-HT3 Receptor Agonists Based on a Pyrroloquinoxaline Structure 195
Synthesis of 6-(4-Methyl-1-piperazinyl)-7H-indeno[2,1-c]quinoline Derivatives as Potential 5-HT Receptor Ligands 195
Novel Basic Derivatives of Benz[e]isoindol-1-ones and Pyrrolo[3,4-c]quinolin-1-ones with 5-HT3 Antagonistic Activity, their Preparation and their Therapeutic Use 194
Structure-Property Relationships in Densely Grafted π-Stacked Polymers 193
Mapping and Fitting the Peripheral Benzodiazepine Receptor Binding Site by Carboxamide Derivatives. Comparison of Different Approaches to Quantitative Ligand-Receptor Interaction Modeling 193
Structure-Activity Relationships in Carboxamide Derivatives Based on the Targeted Delivery of Radionuclides and Boron Atoms by Means of Peripheral Benzodiazepine Receptor Ligands 192
Molecular Basis of Peripheral vs Central Benzodiazepine Receptor Selectivity in a New Class of Peripheral Benzodiazepine Receptor Ligands Related to Alpidem 192
New red-shifted coelenterazine analogues with an extended electronic conjugation 190
Further studies on imidazo[4,5-b]pyridine AT1 angiotensin II receptor antagonists. Effects of the transformation of the 4-phenylquinoline backbone into 4-phenylisoquinolinone or 1-phenylindene scaffolds 189
Synthesis of 1,2,4,-Triazolo[4',3':1,6]pyridazino[4,5-b]quinoline Derivatives 188
Synthesis and Characterization of a New Benzofulvene Polymer Showing a Thermoreversible Polymerization Behavior 187
Characterization of Quinoline Derivatives. Part 3. Mass Spectrometry and X-ray Crystallography of Biologically Interesting Arylquinolines 187
Heterotricyclic Amide Derivatives as Neurokinin-1 (NK1) Receptor Ligands 186
Characterization and Differentiation of Heterocyclic Isomers. Part 2. Mass Spectrometry and Molecular Orbital Calculations on Pyrrolo[1,2-a][1,4]benzodiazepin-4-one, -6-one, -4,6-dione 184
Multivalent Supramolecular Dendrimer-Based Drugs 183
Determination of a novel angiotensin-AT1 Antagonist CR3210, in biological samples by HPLC 183
Ethyl 8-Fluoro-6-(3-nitrophenyl)-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate as Novel, Highly Potent, and Safe Antianxiety Agent 181
New Insight into the Central Benzodiazepine Receptor-Ligand Interactions: Design, Synthesis, Biological Evaluation, and Molecular Modeling of 3-Substituted 6-Phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and Related Compounds 179
CoMFA Analysis of Ligands of the Mitochondrial Benzodiazepine Receptor: A Versatile Tool for the Design of New Lead Compounds 173
Molecular Structure and Dynamics of Some Potent 5-HT3 Receptor Antagonists. Insight into the Interaction with the Receptor 170
Further Studies on the Interaction of 5-Hydroxytryptamine3 (5-HT3) Receptor with Arylpiperazine Ligands. Development of a New 5-HT3 Receptor Ligand Showing Potent Acetylcholinesterase Inhibitory Properties 170
null 169
Design, Synthesis, Structural Studies, Biological Evaluation, and Computational Simulations of Novel Potent AT1 Angiotensin II Receptor Antagonists Based on the 4-Phenylquinoline Structure 167
Hyaluronan derivatives bearing variable densities of ferulic acid residues 167
Structure–affinity relationship studies on arylpiperazine derivatives related to quipazine as serotonin transporter ligands. Molecular basis of the selectivity SERT/5-HT3 receptor 165
Synthesis, Resolution, and Absolute Configuration of Two Novel and Selective Cyclooxygenase-2 Inhibitors Based on 1,5-Diarylpyrrole Structure 163
Synthesis and Biological Characterization of Novel 2-Quinolinecarboxamide Ligands of the Peripheral Benzodiazepine Receptors Bearing Technetium-99m or Rhenium 162
Synthesis, Biological Evaluation and Receptor Docking Simulations of 2-[(Acylamino)ethyl]-1,4-benzodiazepines as k-Opioid Receptor Agonists Endowed with Antinociceptive and Antiamnestic Activity 162
Novel polybenzofulvene derivatives: synthesis and uses thereof 162
Novel potent 5-HT3 receptor ligands based on the pyrrolidone structure: synthesis, biological evaluation, and computational rationalization of the ligand-receptor interaction modalities 161
Synthesis and structure-activity relationship studies in peripheral benzodiazepine receptor ligands related to alpidem 159
Novel Potent 5-HT3 Receptor Ligands Based on the Pyrrolidone Structure. Effects of the Quaternization of the Basic Nitrogen on the Interaction with 5-HT3 Receptor 156
Novel Potent and Selective 5-HT3 Receptor Antagonists Based on Arylpiperazine Skeleton: Synthesis, Structure, Biological Activity and CoMFA Studies 155
Evaluation of Three Quinoline-Carboxamide Derivatives as Potential Radioligands for the in Vivo PET Imaging of Neurodegeneration 152
Synthesis and Benzodiazepine Receptors Affinity of 2,3-Dihydro-9- phenyl-1H-pyrrolo[3,4-b]quinolin-1-one and 3-Carbethoxy-4-phenylquinoline Derivatives 149
Labeling and Evaluation of N-[11C]Methylated Quinoline-2-carboxamide as Potential Radioligands for Visualization of Peripheral Benzodiazepine Receptors 146
Synthesis and 5-HT Receptors Binding Studies of Some 3-Substituted-2-(4-methyl-1-piperazinyl)-4-phenylquinolines 144
Novel Potent and Selective Central 5-HT3 Receptor Ligands Provided with Different Intrinsic Efficacy. 2. Molecular Basis of the Intrinsic Efficacy of Arylpiperazine Derivatives at the Central 5-HT3 Receptors 144
π-Stacked polymers in drug delivery applications 139
The Interaction of the 5-HT3 Receptor with Arylpiperazine, Tropane, and Quinuclidine Ligands 138
Reversible Polymerization Techniques Leading to pi-Stacked Polymers 138
Imidazo[1,2-a]pyrazin-3(7H)-one Derivatives Bearing a New Electron-Rich Structure. 136
Enzymatic and Molecular Modeling Studies of 5-HT3 Receptor Ligands Based on Pyrroloquinoline Structure and Provided with Acetylcholinesterase Inhibitory Activity 134
Synthesis of 4-Substituted-1,2,3,4-tetrahydro-11-phenyl-5H-azepino[3,4-b]quinolin-5-one as Potential Peripheral Benzodiazepine-receptor Ligands 130
Synthesis of the Novel [11C]-Labelled Quinoline Carboxamides: Analogues of PK-11195 as Putative Radioligands for PET Studies of Peripheral Type Benzodiazepine Receptors 128
Synthesis and Receptor Binding Studies of 2-Functionalized 1,4-Benzodiazepine Derivatives as Potential Metaclazepam-like Antianxiety Agents 122
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. I. Mapping the central 5-HT3 recceptor binding site by arylpiperazine derivatives 121
Synthesis and 5-HT-Receptors Affinity of Some 4-Phenylquinoline Derivatives 118
Synthesis of 2,10-Diphenyl-2H-pyridazino[4,5-b]quinolin-1-one and 2,3-Dihydro-9-phenyl-2-phenylamino-1H-pyrrolo[3,4-b]quinolin-1-one Derivatives as Peripheral-type Benzodiazepine Receptors Ligands 108
Totale 16.116
Categoria #
all - tutte 49.135
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.135


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022929 0 151 31 174 38 14 54 25 39 104 86 213
2022/20231.420 90 108 188 210 135 296 35 106 135 36 56 25
2023/2024924 26 9 103 36 31 277 327 30 0 1 4 80
2024/20251.907 32 114 172 81 277 84 18 90 119 77 206 637
2025/20264.541 354 715 657 511 768 136 440 99 143 247 80 391
2026/2027329 197 132 0 0 0 0 0 0 0 0 0 0
Totale 16.116